OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma
Jianfei Huang, Xialing Zhang, Qi Tang, et al.
Journal of Clinical Pathology (2011) Vol. 64, Iss. 4, pp. 343-348
Closed Access | Times Cited: 88
Jianfei Huang, Xialing Zhang, Qi Tang, et al.
Journal of Clinical Pathology (2011) Vol. 64, Iss. 4, pp. 343-348
Closed Access | Times Cited: 88
Showing 1-25 of 88 citing articles:
VEGF targets the tumour cell
Hira Lal Goel, Arthur M. Mercurio
Nature reviews. Cancer (2013) Vol. 13, Iss. 12, pp. 871-882
Open Access | Times Cited: 1147
Hira Lal Goel, Arthur M. Mercurio
Nature reviews. Cancer (2013) Vol. 13, Iss. 12, pp. 871-882
Open Access | Times Cited: 1147
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Andrew X. Zhu, Joon Oh Park, Baek‐Yeol Ryoo, et al.
The Lancet Oncology (2015) Vol. 16, Iss. 7, pp. 859-870
Closed Access | Times Cited: 788
Andrew X. Zhu, Joon Oh Park, Baek‐Yeol Ryoo, et al.
The Lancet Oncology (2015) Vol. 16, Iss. 7, pp. 859-870
Closed Access | Times Cited: 788
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer
Sònia Tugues, Sina Koch, Laura Gualandi, et al.
Molecular Aspects of Medicine (2011) Vol. 32, Iss. 2, pp. 88-111
Closed Access | Times Cited: 198
Sònia Tugues, Sina Koch, Laura Gualandi, et al.
Molecular Aspects of Medicine (2011) Vol. 32, Iss. 2, pp. 88-111
Closed Access | Times Cited: 198
Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC
Xiaolu Zhai, Huijun Zhu, Wei Wang, et al.
Medical Oncology (2014) Vol. 31, Iss. 6
Closed Access | Times Cited: 112
Xiaolu Zhai, Huijun Zhu, Wei Wang, et al.
Medical Oncology (2014) Vol. 31, Iss. 6
Closed Access | Times Cited: 112
Safranal Inhibits Angiogenesis via Targeting HIF-1α/VEGF Machinery: In Vitro and Ex Vivo Insights
Ali Abdalla, Chandraprabha Murali, Amr Amin
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 42
Ali Abdalla, Chandraprabha Murali, Amr Amin
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 42
Vascular Endothelial Growth Factor Receptor 2 as a Marker for Malignant Vascular Tumors and Mesothelioma
Markku Miettinen, Maarit-Sarlomo Rikala, Janusz Ryś, et al.
The American Journal of Surgical Pathology (2012) Vol. 36, Iss. 4, pp. 629-639
Open Access | Times Cited: 98
Markku Miettinen, Maarit-Sarlomo Rikala, Janusz Ryś, et al.
The American Journal of Surgical Pathology (2012) Vol. 36, Iss. 4, pp. 629-639
Open Access | Times Cited: 98
Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma
Sui Peng, Ye Wang, Hong Peng, et al.
Hepatology (2014) Vol. 60, Iss. 4, pp. 1264-1277
Open Access | Times Cited: 90
Sui Peng, Ye Wang, Hong Peng, et al.
Hepatology (2014) Vol. 60, Iss. 4, pp. 1264-1277
Open Access | Times Cited: 90
FoxQ1 Overexpression Influences Poor Prognosis in Non-Small Cell Lung Cancer, Associates with the Phenomenon of EMT
Jian Feng, Xuesong Zhang, Huijun Zhu, et al.
PLoS ONE (2012) Vol. 7, Iss. 6, pp. e39937-e39937
Open Access | Times Cited: 79
Jian Feng, Xuesong Zhang, Huijun Zhu, et al.
PLoS ONE (2012) Vol. 7, Iss. 6, pp. e39937-e39937
Open Access | Times Cited: 79
Nicotinamide N-methyltransferase: a potential biomarker for worse prognosis in gastric carcinoma.
Chen Chen, Xin Wang, Xing Huang, et al.
PubMed (2016) Vol. 6, Iss. 3, pp. 649-63
Closed Access | Times Cited: 67
Chen Chen, Xin Wang, Xing Huang, et al.
PubMed (2016) Vol. 6, Iss. 3, pp. 649-63
Closed Access | Times Cited: 67
High Expression of FoxP1 Is Associated With Improved Survival in Patients With Non–Small Cell Lung Cancer
Jian Feng, Xuesong Zhang, Huijun Zhu, et al.
American Journal of Clinical Pathology (2012) Vol. 138, Iss. 2, pp. 230-235
Open Access | Times Cited: 72
Jian Feng, Xuesong Zhang, Huijun Zhu, et al.
American Journal of Clinical Pathology (2012) Vol. 138, Iss. 2, pp. 230-235
Open Access | Times Cited: 72
Personalized therapy for hepatocellular carcinoma: Where are we now?
Stephen L. Chan, Alissa Michelle Go Wong, Kirsty Lee, et al.
Cancer Treatment Reviews (2016) Vol. 45, pp. 77-86
Closed Access | Times Cited: 57
Stephen L. Chan, Alissa Michelle Go Wong, Kirsty Lee, et al.
Cancer Treatment Reviews (2016) Vol. 45, pp. 77-86
Closed Access | Times Cited: 57
Use of VEGFR-2 Targeted Ultrasound Contrast Agent for the Early Evaluation of Response to Sorafenib in a Mouse Model of Hepatocellular Carcinoma
Marco Baron Toaldo, Veronica Salvatore, Sara Marinelli, et al.
Molecular Imaging and Biology (2014) Vol. 17, Iss. 1, pp. 29-37
Closed Access | Times Cited: 55
Marco Baron Toaldo, Veronica Salvatore, Sara Marinelli, et al.
Molecular Imaging and Biology (2014) Vol. 17, Iss. 1, pp. 29-37
Closed Access | Times Cited: 55
CD133+ cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma
Kai Liu, Meijun Hao, Yabo Ouyang, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 53
Kai Liu, Meijun Hao, Yabo Ouyang, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 53
Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma
Yixin Zhang, Suqin Zhang, Xudong Wang, et al.
Journal of Clinical Pathology (2012) Vol. 65, Iss. 6, pp. 528-533
Closed Access | Times Cited: 50
Yixin Zhang, Suqin Zhang, Xudong Wang, et al.
Journal of Clinical Pathology (2012) Vol. 65, Iss. 6, pp. 528-533
Closed Access | Times Cited: 50
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma
Claudio Luchini, Paola Capelli, Matteo Fassan, et al.
Journal of Clinical Oncology (2014) Vol. 32, Iss. 17, pp. e63-e66
Open Access | Times Cited: 48
Claudio Luchini, Paola Capelli, Matteo Fassan, et al.
Journal of Clinical Oncology (2014) Vol. 32, Iss. 17, pp. e63-e66
Open Access | Times Cited: 48
Nuclear Translocation of β-Catenin during Mesenchymal Stem Cells Differentiation into Hepatocytes Is Associated with a Tumoral Phenotype
Carmen Herencia, Julio M. Martínez‐Moreno, Concha Herrera, et al.
PLoS ONE (2012) Vol. 7, Iss. 4, pp. e34656-e34656
Open Access | Times Cited: 47
Carmen Herencia, Julio M. Martínez‐Moreno, Concha Herrera, et al.
PLoS ONE (2012) Vol. 7, Iss. 4, pp. e34656-e34656
Open Access | Times Cited: 47
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma
Catia Giovannini, Michele Baglioni, Marco Baron Toaldo, et al.
Oncotarget (2013) Vol. 4, Iss. 10, pp. 1618-1631
Open Access | Times Cited: 47
Catia Giovannini, Michele Baglioni, Marco Baron Toaldo, et al.
Oncotarget (2013) Vol. 4, Iss. 10, pp. 1618-1631
Open Access | Times Cited: 47
Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity
Jian Feng, Liqin Xu, Songshi Ni, et al.
Oncotarget (2014) Vol. 5, Iss. 20, pp. 9689-9702
Open Access | Times Cited: 46
Jian Feng, Liqin Xu, Songshi Ni, et al.
Oncotarget (2014) Vol. 5, Iss. 20, pp. 9689-9702
Open Access | Times Cited: 46
Applications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells
Elsa N. Garza-Treviño, Adriana G. Quiroz-Reyes, Paulina Delgado‐González, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7791-7791
Open Access | Times Cited: 4
Elsa N. Garza-Treviño, Adriana G. Quiroz-Reyes, Paulina Delgado‐González, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7791-7791
Open Access | Times Cited: 4
High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma
Liang Han, Bin Jiang, Hao Wu, et al.
Medical Oncology (2012) Vol. 29, Iss. 4, pp. 2466-2472
Closed Access | Times Cited: 46
Liang Han, Bin Jiang, Hao Wu, et al.
Medical Oncology (2012) Vol. 29, Iss. 4, pp. 2466-2472
Closed Access | Times Cited: 46
Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Hans Bösmüller, Vanessa Pfefferle, Zeid Bittar, et al.
Pathology - Research and Practice (2018) Vol. 214, Iss. 8, pp. 1136-1141
Closed Access | Times Cited: 38
Hans Bösmüller, Vanessa Pfefferle, Zeid Bittar, et al.
Pathology - Research and Practice (2018) Vol. 214, Iss. 8, pp. 1136-1141
Closed Access | Times Cited: 38
SK-Hep1: not hepatocellular carcinoma cells but a cell model for liver sinusoidal endothelial cells.
Yang Tai, Jinhang Gao, Chong Zhao, et al.
PubMed (2018) Vol. 11, Iss. 5, pp. 2931-2938
Closed Access | Times Cited: 36
Yang Tai, Jinhang Gao, Chong Zhao, et al.
PubMed (2018) Vol. 11, Iss. 5, pp. 2931-2938
Closed Access | Times Cited: 36
Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.
Liang Han, Bin Jiang, Hao Wu, et al.
PubMed (2014) Vol. 7, Iss. 10, pp. 6734-42
Closed Access | Times Cited: 35
Liang Han, Bin Jiang, Hao Wu, et al.
PubMed (2014) Vol. 7, Iss. 10, pp. 6734-42
Closed Access | Times Cited: 35
PET Imaging of VEGFR with a Novel 64Cu-Labeled Peptide
Kuan Hu, Jingjie Shang, Lin Xie, et al.
ACS Omega (2020) Vol. 5, Iss. 15, pp. 8508-8514
Open Access | Times Cited: 28
Kuan Hu, Jingjie Shang, Lin Xie, et al.
ACS Omega (2020) Vol. 5, Iss. 15, pp. 8508-8514
Open Access | Times Cited: 28
